As part of our commitment to fight global health challenges, we were a founding member of WIPO Re:Search, a new open innovation platform which aims to help accelerate the development of new and better treatments against neglected tropical diseases such as dengue, rabies and Chagas disease, as well as malaria and tuberculosis.

WIPO Re:Search is a collaboration of private and public sector organisations sponsored by the World Intellectual Property Organization (WIPO) in collaboration with BIO Ventures for Global Health (BVGH).

This collaboration builds on the Pool for Open Innovation against Neglected Tropical Diseases, which was established in February 2009 with patents from GSK and Alnylam Pharmaceuticals. This intellectual property (IP) pool was the first effort to ensure IP did not act as a barrier to research for neglected tropical diseases.

A coordinated approach to developing new treatments for these diseases - which disproportionately affect the least developed countries - is needed. To successfully meet the challenges in global health drug development, new partnerships and new approaches must be formed between organisations with a new mindset - one which is more innovative, flexible, and willing to take risks. We are committed to being actively involved.

For further information go to the WIPO Re:Search website.